- Report
- January 2025
- 207 Pages
Global
From €2228EUR$2,500USD£1,927GBP
- Report
- July 2024
- 163 Pages
Global
From €2228EUR$2,500USD£1,927GBP
- Report
- August 2024
- 322 Pages
Global
From €3744EUR$4,200USD£3,237GBP
- Report
- May 2025
- 115 Pages
Global
From €4234EUR$4,750USD£3,661GBP
- Report
- April 2025
- 183 Pages
Global
From €4011EUR$4,500USD£3,469GBP
- Report
- March 2025
- 120 Pages
North America
From €3566EUR$4,000USD£3,083GBP
- Report
- October 2024
- 82 Pages
India
From €3120EUR$3,500USD£2,698GBP
- Report
- August 2024
- 124 Pages
Europe
From €3566EUR$4,000USD£3,083GBP
- Report
- July 2024
- 80 Pages
Japan
From €3120EUR$3,500USD£2,698GBP
- Report
- May 2024
- 182 Pages
Global
From €4011EUR$4,500USD£3,469GBP
- Report
- February 2024
- 170 Pages
Global
From €4011EUR$4,500USD£3,469GBP
- Report
- August 2023
- 74 Pages
United States
From €3120EUR$3,500USD£2,698GBP
- Report
- August 2023
- 75 Pages
Canada
From €3120EUR$3,500USD£2,698GBP
- Report
- June 2025
- 185 Pages
Global
From €4011EUR$4,500USD£3,469GBP
- Report
- January 2025
- 82 Pages
Vietnam
From €3120EUR$3,500USD£2,698GBP
- Report
- January 2025
- 183 Pages
Global
From €4011EUR$4,500USD£3,469GBP
- Report
- December 2024
- 87 Pages
Spain
From €3120EUR$3,500USD£2,698GBP
- Report
- August 2024
- 80 Pages
United States
From €3120EUR$3,500USD£2,698GBP
- Report
- August 2024
- 80 Pages
Spain
From €3120EUR$3,500USD£2,698GBP
- Report
- August 2024
- 80 Pages
Saudi Arabia
From €3120EUR$3,500USD£2,698GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more